A novel phenolic propanediamine moiety-based lung-targeting therapy for asthma

Drug Delivery
Jianbo LiJinjie Zhang

Abstract

Asthma is one of the most prevalent chronic inflammatory diseases of lung. Current asthma therapy using inhaled corticosteroid often results in undesired treatment outcome due to poor compliance and drugs' lack of tissue specificity. N,N,N'-trimethyl-N'-(2-hydroxyl-3-methyl-5-123Iiodobenzyl)-1,3-propanediamine (HIPD), a phenolic propanediamine derivative, has been used as an imaging agent for localized pulmonary diseases. Inspired by this, N,N,N'-trimethyl-N'-(4-hydroxyl-benzyl)-1,3-propanediamine (TPD), a new HIPD analog, was proposed as a lung-targeting ligand and covalently conjugated to an anti-inflammatory compound Rhein for asthma therapy. Cellular uptake efficiency of TPD-Rhein by A549 cells was significantly enhanced compared with Rhein. The enhanced cellular uptake was mainly mediated by organic cation transporters (OCTs) in an active manner, showing concentration- and energy-dependent. After systemic administration in rats, TPD-Rhein specifically distributed to lungs, displaying the highest Cmax and AUC0-t values of all tested tissues and resulting in a 13-fold increase in Cmax and a 103-fold increase in AUC0-t for lung compared with Rhein. Also, TPD-Rhein remarkably decreased serum histamine levels, serum IL-5 levels...Continue Reading

References

Jan 1, 1990·International Journal of Radiation Applications and Instrumentation. Part A, Applied Radiation and Isotopes·S M MoerleinM J Welch
Jan 1, 1988·European Journal of Nuclear Medicine·W J ShihH F Kung
Jan 1, 1985·Annual Review of Pharmacology and Toxicology·J R BendR M Philpot
Nov 1, 1996·The European Respiratory Journal·M MiniatiM Pistolesi
Mar 16, 2002·Gene Therapy·I V BalyasnikovaS M Danilov
Aug 29, 2006·Drug Discovery Today·Arun K IyerHiroshi Maeda
Mar 4, 2008·Advanced Drug Delivery Reviews·Karina R Vega-VillaNeal M Davies
Jul 9, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Takashi OkuraYoshiharu Deguchi
Jun 18, 2010·Trends in Pharmacological Sciences·Peter J Barnes
Jan 1, 2010·Advances in Experimental Medicine and Biology·Paul J Dunford, Stephen T Holgate
Jul 27, 2011·Current Drug Metabolism·Murray J Cutler, Edna F Choo
Aug 5, 2011·Drug Delivery·Fengliang CaoGuangxi Zhai
Oct 18, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Beverly A Teicher, Ravi V J Chari
Jun 5, 2012·Drug Discovery Today·Christine R KeenanAlastair G Stewart
Oct 27, 2012·Respiratory Medicine·UNKNOWN Inhaler Error Steering CommitteeJ Bousquet
Dec 1, 2012·Nature Reviews. Drug Discovery·Girolamo PelaiaRosario Maselli
Mar 2, 2013·Angewandte Chemie·Sanjun ShiXun Sun
Sep 18, 2013·Amino Acids·Silvia GrancaraAntonio Toninello
May 29, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Sanjun ShiLaichun Lu
Oct 19, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Meiling ZhouZhirong Zhang

❮ Previous
Next ❯

Methods Mentioned

BETA
column chromatography
protein assay
ELISA
bronchoalveolar
lavage
bronchoalveolar lavage

Software Mentioned

DAS

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

© 2022 Meta ULC. All rights reserved